Elos Medtech’s application for de-listing has been approved
Elos Medtech AB (publ)’s (“Elos Medtech” or the “Company”) application for de-listing has now been approved by Nasdaq Stockholm. The last day of trading in Elos Medtech’s shares on Nasdaq Stockholm will be 19 December 2023. As previously announced, Elos Medtech has applied for de-listing of the Company’s shares from Nasdaq Stockholm. Nasdaq Stockholm has now approved the application and resolved that the last day of trading will be 19 December 2023. For further information, please contact: Stefano Alfonsi, President and CEO, +44 772 04 98 342, email: stefano.alfonsi@elosmedtech.com